EXPLORE!

Medical Voice 10th September 2020

  742 Views

Dr KK Aggarwal    10 September 2020

New system taps weather data to predict outbreaks

PUNE: Experts from the Indian Institute of Tropical Meteorology (IITM), India Meteorological Department (IMD) and the state health department’s Integrated Disease Surveillance Programme have developed an ‘Early Health Warning System’ which, they said, can predict the outbreak of diseases such as malaria, diarrhoea, dengue at least two to three weeks in advance. Changes in rainfall and temperature patterns play a major role in incidence of disease, scientists have found. It’s for this reason that a disease warning system that includes weather data is a significant development, especially during the Covid-19 outbreak. ....read more

Is a vaccine for COVID-19 a hype or a reality?

Join us today at 7:00 PM in MEDtalks with Dr K K Aggarwal as we discuss all about the prevention and eradication of COVID-19. Just click on www.facebook.com/drkkaggarwal or https://perfecthealthmela.com/vevent/general-webinar.php

CMAAO Coronavirus Facts and Myth Buster: CMAAO and COVID-19 Update

With input from Dr Monica Vasudev 1077: Minutes of Virtual Meeting of CMAAO NMAs on “One year of CMAAO & COVID-19 Update” 5th August, 2020, Saturday, 9.30 am-10.30 am, Participants, Member NMAs ,Dr KK Aggarwal, President, CMAAO; Dr Marthanda Pillai, Member, World Medical Council; Dr Yeh Woei Chong, Singapore Chair, CMAAO; Dr Ravi Naidu, Malaysia, Immediate Past President, CMAAO; Dr N Gnanabaskaran, President, Malaysian Medical Association; Dr Alvin Yee-Shing Chan, Hong Kong; Dr Marie Uzawa Urabe, Japan; Dr Prakash Budhathoky, Nepal Dr Tashi Tenzin, Bhutan’Dr Md Jamaluddin Chowdhury, Bangladesh ....read more

World COVID Meter 8th September: Acute manageable immunogenic thrombogenic inflammatory viral disease pandemic

With input from Dr Monica Vasudev Cases: 1M April 2, 2M April 15, 3M April 27, 4M May 8, 5M May 20, 6M May 30, 7M June 7, 8M June 15, 9M June 22, 10M June 29th, 11M July 4, 12M July 8, 13M July 13, 14M July 17, 15M July 23, 16M July 25, 17M July 29, 18M August 1, 19M August 6, 20M August 10, 21M August 16, 22M August 19, 23M August 21, 24M August 27, 25M August 30, 26M September 3 Ground Zero: Wuhan - in live animal market or cafeteria for animal pathogens: 10th January; Total cases are based on RT PCR, 67% sensitivity Coronavirus Cases: 27,484,588,Deaths: 896,796 ,Recovered: 19,585,199....read more

Facts about Soul and the Spirit

Energy is the raw material of the universe.Information is the organization of energy into reproducible patterns.Consciousness is living information and energy (living energized information).Consciousness is, therefore, intelligence. ....read more

Video of The day

Adult Vaccination

Healthcare News Monitor

Volumes spurt at Astrazeneca Pharma India Ltd counter

Business Standard

Astrazeneca Pharma India Ltd registered volume of 10.12 lakh shares by 14:19 IST on NSE, a 6.75 fold spurt over two-week average daily volume of 1.50 lakh shares Indoco Remedies Ltd, Bharat Dynamics Ltd, Redington India Ltd, Amber Enterprises India Ltd are among the other stocks to see a surge in volumes on NSE today, 08 September 2020. Astrazeneca Pharma India Ltd registered volume of 10.12 lakh shares by 14:19 IST on NSE, a 6.75 fold spurt over two-week average daily volume of 1.50 lakh shares. The stock slipped 6.25% to Rs.4,268.05. Volumes stood at 5.52 lakh shares in the last session.

E-pharma set to revolutionise drug market access in India: GlobalData

ExpressPharma

The COVID-19 induced lockdown resulted in an unprecedented rise in e-commerce transactions across India. In line with this, e-pharma sector also witnessed growth despite regulatory challenges. Against this backdrop, e-pharma space is all set to revolutionise drug market access in the country, says GlobalData. Anupama Mishra, Pharma Analyst at GlobalData, comments, “One of the reasons for the recent higher uptake of e-pharma can be attributed to top e-pharma players such as Netmeds and PharmEasy providing e-consultation services and offering heavy discounts to their end consumers. It is eventually expected that there will be a significant rise in their consumer base as COVID-19 cases are rising at an alarming rate in India.” According to GlobalData COVID-19 dashboard, as of 08 September 2020, India has 4,280,422 confirmed cases and the dashboard forecasts 99,158,507 confirmed cases in a low transmission risk scenario as on 17 September 2020.

Alongside Dhannipur mosque in Ayodhya, a 200-bed multi-specialty hospital

HT

The hospital that would come up on the 5-acre land in Dhannipur village in Ayodhya along with the mosque would be a multi-specialty 200-bed hospital with world class facilities, the Indo-Islamic Cultural Foundation (IICF) said. IICF is the trust set up by the Uttar Pradesh Sunni Central Waqf Board (UPSCWB) for the construction of the mosque at Ayodhya on the land allotted by the UP government in compliance with the Supreme Court order. The hospital will be part of Indo-Islamic Centre Complex in Ayodhya village that will also include a community kitchen and an Indo-Islamic Research Centre. The research centre will have a museum and a library too.

COVAXIN, Indias coronavirus vaccine, may be launched in early 2021: AIIMS doctor

India TV

Coronavirus is raging like wildfire across the country, making India the second worst-hit country after the United States. But there is a bright spot amid this mayhem -- Indias first indigenous coronavirus vaccine, Covaxin developed by Hyderabad-based Bharat Biotech, is likely to be launched in early 2021. Covaxin has successfully completed Phase 1 trials and the Centre has given its approval for Phase 2 of clinical trials from September 7. Speaking to IANS, Sanjay Rai, Professor, Community Medicine, and Principal Investigator for Covid-19 vaccine trial at AIIMS, said: "Phase 1 trial has been successfully completed. Phase 2 trial is most likely to get completed sometime in October. After this, the Phase 3 trial will begin. Covaxin may be launched in early 2021 (after completion of all trial stages)."

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.